Saltar al contenido
RecuperaciónEstudio de cohorte3 min read

Higher HRV (SDNN, RMSSD) is linked to more new atrial fibrillation, especially in women

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Heart rate variability and atrial fibrillation in the general population: a longitudinal and Mendelian randomization study. · Clinical research in cardiology : official journal of the German Cardiac Society · 2022 · Artículo original ↗

Idea principal

In 12,334 adults from the Rotterdam Study, higher SDNN (HR 1.24) and higher RMSSD (HR 1.33) were associated with new atrial fibrillation (AF) over a median 9.4 years, mostly in women. Genetic analyses pointed the same way, but they are only a proxy for causation and do not show that changing your own HRV would change AF risk.

Study design

Estudio de cohorte

Reading basis

Published abstract

Reading focus

Association & confounding

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Heart rate variability (HRV) is widely tracked, yet whether it is related to atrial fibrillation, and whether that relationship differs between men and women, was unclear. The authors tested whether repeated HRV measures predict new-onset AF in the general population, and used genetic variants to ask whether the relationship might be causal.

Población y método

Two approaches. First, a longitudinal analysis of 12,334 AF-free participants of the population-based Rotterdam Study, with SDNN (standard deviation of normal RR intervals), heart-rate-corrected SDNN (SDNNc), RMSSD (root mean square of successive RR interval differences), corrected RMSSD (RMSSDc) and heart rate measured at baseline and follow-up. Joint models, adjusted for cardiovascular risk factors, linked repeated HRV with new-onset AF. Second, a Mendelian randomization (MR) analysis used genetic variants for HRV as instruments with summary data from genome-wide association studies (HRV n = 53,174; AF n = 1,030,836).

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Over a median follow-up of 9.4 years, 1302 participants developed AF (mean age 64.8 years, 58.3% women).
  2. 2
    In fully adjusted joint models, higher SDNN (HR 1.24, 95% CI 1.04-1.47, p = 0.0213) and higher RMSSD (HR 1.33, 95% CI 1.13-1.54, p = 0.0010) were associated with new AF. In sex-stratified analyses the associations were mostly prominent among women.
  3. 3
    In MR analyses, a genetically determined increase in SDNN (OR 1.60, 95% CI 1.27-2.02, p = 8.36 × 10^(-05)) and in RMSSD (OR 1.56, 95% CI 1.31-1.86, p = 6.32 × 10^(-07)) was associated with higher odds of AF. The conclusions apply to the uncorrected (not heart-rate-corrected) measures.

Límites e incertidumbre

  1. 1
    The longitudinal part is observational; the participants were mostly older (mean age 64.8 years), so the findings may not apply to young or athletic people.
  2. 2
    HRV was measured in a research setting, not by consumer wearables, and the signal differed once corrected for heart rate.
  3. 3
    MR rests on assumptions such as no pleiotropy (genes acting through other routes), and the authors' suggestion that modulating HRV might prevent AF was not tested in any intervention. This reading is based on the abstract only.

Relevancia práctica

Higher HRV is usually seen as favourable, so a link with more AF is a surprise, but it was found in a group of mostly older adults and does not mean a high HRV on your device is a warning sign. Do not try to lower your HRV, and if you have palpitations or an irregular pulse, see a clinician.

Tus datos

Wearable HRV is typically measured with different methods and timing than a clinical ECG, so you cannot read these study thresholds into your own number. If you track HRV, compare your own readings with the same device and conditions over weeks, and raise any irregular-rhythm alerts with your clinician.

Cómo interpretar la evidencia

Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

Sex differences and causality of the association between heart rate variability (HRV) and atrial fibrillation (AF) in the general population remain unclear.

Methods

12,334 participants free of AF from the population-based Rotterdam Study were included. Measures of HRV including the standard deviation of normal RR intervals (SDNN), SDNN corrected for heart rate (SDNNc), RR interval differences (RMSSD), RMSSD corrected for heart rate (RMSSDc), and heart rate were assessed at baseline and follow-up examinations. Joint models, adjusted for cardiovascular risk factors, were used to determine the association between longitudinal measures of HRV with new-onset AF. Genetic variants for HRV were used as instrumental variables in a Mendelian randomization (MR) analysis using genome-wide association studies (GWAS) summary-level data.

Results

During a median follow-up of 9.4 years, 1302 incident AF cases occurred among 12,334 participants (mean age 64.8 years, 58.3% women). In joint models, higher SDNN (fully-adjusted hazard ratio (HR), 95% confidence interval (CI) 1.24, 1.04-1.47, p = 0.0213), and higher RMSSD (fully-adjusted HR, 95% CI 1.33, 1.13-1.54, p = 0.0010) were significantly associated with new-onset AF. Sex-stratified analyses showed that the associations were mostly prominent among women. In MR analyses, a genetically determined increase in SDNN (odds ratio (OR), 95% CI 1.60, 1.27-2.02, p = 8.36 × 10^(-05)), and RMSSD (OR, 95% CI 1.56, 1.31-1.86, p = 6.32 × 10^(-07)) were significantly associated with an increased odds of AF.

Conclusion

Longitudinal measures of uncorrected HRV were significantly associated with new-onset AF, especially among women. MR analyses supported the causal relationship between uncorrected measures of HRV with AF. Our findings indicate that measures to modulate HRV might prevent AF in the general population, in particular in women. AF; atrial fibrillation, GWAS; genome-wide association study, IVW; inverse variance weighted, MR; Mendelian randomization, MR-PRESSO; MR-egger and mendelian randomization pleiotropy residual sum and outlier, RMSSD; root mean square of successive RR interval differences, RMSSDc; root mean square of successive RR interval differences corrected for heart rate, SDNN; standard deviation of normal to normal RR intervals, SDNNc; standard deviation of normal to normal RR intervals corrected for heart rate, WME; weighted median estimator. ^(a)Rotterdam Study n=12,334 ^(b)HRV GWAS n=53,174 ^(c)AF GWAS n=1,030,836.

Fuentes y atribución

Heart rate variability and atrial fibrillation in the general population: a longitudinal and Mendelian randomization study.

Geurts S, Tilly MJ, Arshi B, Stricker BHC, Kors JA, Deckers JW, de Groot NMS, Ikram MA, Kavousi M.

Clinical research in cardiology : official journal of the German Cardiac Society · 2022-08-13

DOI: 10.1007/s00392-022-02072-5 ↗PubMed · 35962833 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Artículo de investigación

Short-term HRV was higher during slow breathing in 962 military men, injured or not

In 962 military men (median age 37.6 years), every short-term heart rate variability (HRV) measure was higher during slow breathing at six breaths a minute than during spontaneous breathing, injured or not; in fast resting breathers RMSSD rose from 15.57 to 21.89 ms. It was one session in a fixed order, so it shows an immediate effect, not lasting benefit.

European Journal of Applied Physiology

Explicaciones detalladasLeer estudio →
·Metaanálisis de ensayos

Cold-water immersion: no strength gain, briefly weaker jumps, soreness relief uncertain

Across 22 randomised trials (375 participants, mostly men), one cold-water immersion after exercise did not change maximal isometric strength (g 0.08, 95% CI −0.11 to 0.26) and was followed by weaker jumping straight afterwards (g −0.68), gone by 24–48 hours. Lower soreness and creatine kinase looked favourable but weakened in sensitivity checks, and certainty was low to very low.

PeerJ

Explicaciones detalladasLeer estudio →
·Revisión de evidencia

Cold-water immersion after hard exercise: less soreness, better power, no strength gain

In a meta-analysis of 52 randomised trials, cold-water immersion after high-intensity exercise was followed 24 hours later by lower soreness (SMD −0.89), higher perceived recovery (0.66) and better muscular power (0.22), with no effect on strength. Participants could not be blinded, most were men, and many pooled results rest on few studies with high heterogeneity.

Sports Medicine

Explicaciones detalladasLeer estudio →
·Métodos e interpretación

Acute:chronic workload ratio: no evidence it can reduce injury risk, authors argue

The authors argue there is no evidence for using the acute:chronic workload ratio (ACWR) in training-load management or to reduce injury risk: no study has properly estimated a causal effect, and the ratio is statistically inaccurate and ambiguous. This is a methodological critique, not a new data analysis, so it does not show that training load is unrelated to injury.

International Journal of Sports Physiology and Performance

Explicaciones detalladasLeer estudio →
Recuperación →